Boston Private Bank & Trust’s GSK GSK Stock Holding History

Boston Private Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$1.01M	Sell	17,543 -116	-0.7%	-$6.65K	0.05%	231
2014 Q4	$944K	Sell	17,659 -164	-0.9%	-$9.18K	0.04%	240
2014 Q3	$1.02M	Sell	17,823 -1,720	-9%	-$105K	0.05%	231
2014 Q2	$1.31M	Sell	19,543 -1,608	-8%	-$109K	0.06%	216
2014 Q1	$1.41M	Hold	21,151	–	–	0.07%	208
2013 Q4	$1.41M	Buy	21,151 +1,819	+9%	+$118K	0.07%	203
2013 Q3	$1.21M	Hold	19,332	–	–	0.07%	214
2013 Q2	$1.21M	Buy	+19,332	New	+$1.23M	0.07%	207

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Private Bank & Trust's GSK Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its GSK (GSK) stake by 0.66% in Q1 2015, selling an estimated $6.65K and leaving 17,543 shares worth $1.01M. The position accounts for 0.05% of the portfolio, ranked #231.

Boston Private Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.41M in Q1 2014. 741 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

Boston Private Bank & Trust held 17,543 shares of GSK worth $1.01M as of Q1 2015.
Boston Private Bank & Trust sold 116 GSK shares in Q1 2015, an estimated $6.65K.
GSK made up 0.05% of Boston Private Bank & Trust's portfolio in Q1 2015, its #231 holding.
Boston Private Bank & Trust first reported a position in GSK in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's GSK position peaked at $1.41M in Q1 2014.
741 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.